Ocorreu na semana passada, no Rio de Janeiro, o 1º Congresso Internacional sobre os Transtornos do Espectro Autista e o 1º Encontro Internacional de Associações, Familiares e Cuidadores de Autistas. A lista de referências abaixo foi disponibilizada pela nossa colunista Kamila Castro, que abordou temas relacionados à Nutrição e ao TEA.
E o Congresso do próximo ano já tem data marcada. Esperamos todos vocês nos dias 20, 21 e 22 de agosto de 2020!
AFSHIN, Ashkan et al. Health effects of dietary risks in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet, v. 393, n. 10184, p. 1958-1972, may, 2019.
ALONSO-ALONSO, Miguel et al. Food reward system: current perspectives and future research needs. Nutrition reviews, v. 73, n. 5, p. 296-307, may, 2015.
AVERY, Jason A. et al. Neural correlates of taste reactivity in autism spectrum disorder. NeuroImage: Clinical, v. 19, p. 38-46, apr, 2018.
AZHARI, Atiqah; AZIZAN, Farouq; ESPOSITO, Gianluca. A systematic review of gut‐immune‐brain mechanisms in Autism Spectrum Disorder. Developmental psychobiology, p.1-20, dec, 2018.
BARKO, P. C. et al. The gastrointestinal microbiome: a review. Journal of veterinary internal medicine, v. 32, n. 1, p. 9-25, nov, 2018.
BOISON, Detlev. New insights into the mechanisms of the ketogenic diet. Current opinion in neurology, v. 30, n. 2, p. 187-192, apr., 2017.
BOSTOCK, Emmanuelle; KIRKBY, Kenneth C.; TAYLOR, Bruce VM. The current status of the ketogenic diet in psychiatry. Frontiers in psychiatry, v. 8, p. 43-53, mar. 2017.
BURGER, Barrett J. et al. Autistic siblings with novel mutations in two different genes: insight for genetic workups of autistic siblings and connection to mitochondrial dysfunction. Frontiers in Pediatrics, v. 5, p. 219, oct, 2017.
CEKICI, Hande; SANLIER, Nevin. Current nutritional approaches in managing autism spectrum disorder: A review. Nutritional neuroscience, v. 22, n. 3, p. 145-155, aug, 2017.
CHENG, Ning; RHO, Jong M.; MASINO, Susan A. Metabolic dysfunction underlying autism spectrum disorder and potential treatment approaches. Frontiers in molecular neuroscience, v. 10, p. 34, feb, 2017.
DOENYAS, Ceymi. Dietary interventions for autism spectrum disorder: New perspectives from the gut-brain axis. Physiology & behavior, v. 194, p. 577-582, jul, 2018.
ESTES, Myka L.; MCALLISTER, A. Kimberley. Maternal immune activation: implications for neuropsychiatric disorders. Science, v. 353, n. 6301, p. 772-777, aug, 2016.
EVANS, Bonnie. How autism became autism: The radical transformation of a central concept of child development in Britain. History of the Human Sciences, v. 26, n. 3, p. 3-31, may, 2013.
FATTORUSSO, Antonella et al. Autism spectrum disorders and the gut microbiota. Nutrients, v. 11, n. 3, p. 521, feb, 2019.
FERGUSON, Bradley J. et al. The Relationship Among Gastrointestinal Symptoms, Problem Behaviors, and Internalizing Symptoms in Children and Adolescents With Autism Spectrum Disorder. Frontiers in psychiatry, v. 10, apr, 2019.
Lista de Referências de Kamila Castro Grokoski para as palestras do 1º Congresso Internacional de Transtorno do Espectro do Autismo- Atualização Clínica e Científica
FETISSOV, Sergueï O.; AVERINA, Olga V.; DANILENKO, Valery N. Neuropeptides in the microbiota-brain axis and feeding behavior in autism spectrum disorder. Nutrition, v. 61, p. 43-48, may, 2018.
FORMOSA, Luke E. et al. Characterization of mitochondrial FOXRED1 in the assembly of respiratory chain complex I. Human molecular genetics, v. 24, n. 10, p. 2952-2965, feb, 2015.
FOROUHI, Nita G.; UNWIN, Nigel. Global diet and health: old questions, fresh evidence, and new horizons. The Lancet, v. 393, n. 10184, p. 1916-1918, apr, 2019.
FRYE, Richard E. et al. Blocking and binding folate receptor alpha autoantibodies identify novel autism spectrum disorder subgroups. Frontiers in neuroscience, v. 10, p. 80, mar, 2016.
FRYE, Richard E.; SLATTERY, John C.; QUADROS, Edward V. Folate metabolism abnormalities in autism: potential biomarkers. Biomarkers in medicine, v. 11, n. 8, p. 687-699, aug, 2017.
GESCHWIND, Daniel H. Advances in autism. Annual review of medicine, v. 60, p. 367-380, feb, 2009.
GOGOU, M.; KOLIOS, G. Are therapeutic diets an emerging additional choice in autism spectrum disorder management?. World Journal of Pediatrics, v. 14, n. 3, p. 215-223, may, 2018.
GRAF-MYLES, Jennifer et al. Dietary adequacy of children with autism compared to controls and the impact of restricted diet. Journal of developmental and behavioral pediatrics: JDBP, v. 34, n. 7, sep, 2013.
GRIFFITHS, Keren K.; LEVY, Richard J. Evidence of mitochondrial dysfunction in autism: biochemical links, geneticbased associations, and non-energy-related mechanisms. Oxidative medicine and cellular longevity, v. 2017, may, 2017.
GUO, Bao-Qiang et al. Maternal multivitamin supplementation is associated with a reduced risk of autism spectrum disorder in children: A systematic review and meta-analysis. Nutrition Research, v. 65, p. 4-16, may, 2019.
HOLLOWOOD, Kathryn et al. Maternal metabolic profile predicts high or low risk of an autism pregnancy
outcome. Research in Autism Spectrum Disorders, v. 56, p. 72-82, dec, 2018.
HOSIE, Suzanne et al. Gastrointestinal dysfunction in patients and mice expressing the autism‐associated r451c
mutation in neuroligin‐3. Autism Research, may, 2019. [Epub ahead of print]. DOI: https://doi.org/10.1002/aur.2127.
INDRIO, Flavia et al. Epigenetic matters: the link between early nutrition, microbiome, and long-term health
development. Frontiers in Pediatrics, v. 5, p. 178, aug, 2017.
IWATA, Keiko et al. Animal models of autism: an epigenetic and environmental viewpoint. Journal of Central Nervous System Disease, v. 2, p. JCNSD. S6188, nov, 2010.
JENSEN, Frances E. Epilepsy as a spectrum disorder: implications from novel clinical and basic neuroscience. Epilepsia, v. 52, p. 1-6, jan, 2011.
JYONOUCHI, Harumi et al. Variations in mitochondrial respiration differ in IL-1ß/IL-10 ratio based subgroups in autism spectrum disorders. Frontiers in psychiatry, v. 10, feb, 2019.
KAWAMURA JR, Masahito; RUSKIN, David N.; MASINO, Susan A. Metabolic therapy for temporal lobe epilepsy in a dish: investigating mechanisms of ketogenic diet using electrophysiological recordings in hippocampal slices. Frontiers in molecular neuroscience, v. 9, p. 112, nov, 2016.
KNIVSBERG, Ann-Mari; REICHELT, K. L.; NØDLAND, Magne. Reports on dietary intervention in autistic disorders. Nutritional Neuroscience, v. 4, n. 1, p. 25-37, 2001.
KOSSOFF, Eric H.; RHO, Jong M. Ketogenic diets: evidence for short-and long-term efficacy. Neurotherapeutics, v. 6, n. 2, p. 406-414, apr, 2009.
KRAAK, V. I. et al. A novel marketing mix and choice architecture framework to nudge restaurant customers toward healthy food environments to reduce obesity in the United States. Obesity reviews, v. 18, n. 8, p. 852-868, may, 2017.
LEE, Ryan WY et al. A modified ketogenic gluten-free diet with MCT improves behavior in children with autism spectrum disorder. Physiology & behavior, v. 188, p. 205-211, feb, 2018.
LENAZ, Giorgio et al. Complex I function in mitochondrial supercomplexes. Biochimica et Biophysica Acta (BBA) – Bioenergetics, v. 1857, n. 7, p. 991-1000, jan, 2016.
LIU, Hongyan et al. Ketogenic diet for treatment of intractable epilepsy in adults: a meta‐analysis of observational studies. Epilepsia open, v. 3, n. 1, p. 9-17, jan, 2018.
MA, Bingjie et al. Altered Gut Microbiota in Chinese Children With Autism Spectrum Disorders. Frontiers in cellular and infection microbiology, v. 9, mar, 2019.
MABUNGA, Darine Froy N. et al. Exploring the validity of valproic acid animal model of autism. Experimental neurobiology, v. 24, n. 4, p. 285-300, dec, 2015.
MANNION, Arlene; LEADER, Geraldine. Gastrointestinal symptoms in autism spectrum disorder: A literature review. Review Journal of Autism and Developmental Disorders, v. 1, n. 1, p. 11-17, oct, 2014.
MATTA, Samantha M.; HILL-YARDIN, Elisa L.; CRACK, Peter J. The influence of neuroinflammation in Autism Spectrum Disorder. Brain, behavior, and immunity, 2019. [Epub ahead of print]. DOI: https://doi.org/10.1016/j.bbi.2019.04.037.
MAZAHERY, Hajar et al. Vitamin D and Omega-3 Long Chain Polyunsaturated Fatty Acids Improve Behavioural Symptoms in Children with Autism Spectrum Disorder. Multidisciplinary Digital Publishing Institute Proceedings, v. 8, n. 1, p. 58, apr, 2019.
MAZUREK, Micah O. et al. Anxiety, sensory over-responsivity, and gastrointestinal problems in children with autism spectrum disorders. Journal of abnormal child psychology, v. 41, n. 1, p. 165-176, aug, 2013.
MCDONALD, Tanya JW; CERVENKA, Mackenzie C. Ketogenic diets for adults with highly refractory epilepsy. Epilepsy currents, v. 17, n. 6, p. 346-350, nov, 2017.
MCNALLY, Melanie A.; HARTMAN, Adam L. Ketone bodies in epilepsy. Journal of neurochemistry, v. 121, n. 1, p. 28-35, apr, 2012.
MILLWARD, Claire et al. Gluten‐and casein‐free diets for autistic spectrum disorder. Cochrane database of systematic reviews, n. 2, apr, 2008.
MIMAKI, Masakazu et al. Understanding mitochondrial complex I assembly in health and disease. Biochimica et Biophysica Acta (BBA)-Bioenergetics, v. 1817, n. 6, p. 851-862, jun, 2012.
NAPOLI, Eleonora; DUEÑAS, Nadia; GIULIVI, Cecilia. Potential therapeutic use of the ketogenic diet in autism spectrum disorders. Frontiers in pediatrics, v. 2, p. 69, jun, 2014.
PENZOL, María José et al. Functional gastrointestinal disease in autism spectrum disorder: a retrospective descriptive study in a clinical sample. Frontiers in psychiatry, v. 10, apr, 2019.
RINCEL, Marion et al. Multi-hit early life adversity affects gut microbiota, brain and behavior in a sex-dependent manner. Brain, behavior, and immunity, mar, 2019.
RODENBURG, Richard J. Mitochondrial complex I-linked disease. Biochimica et Biophysica Acta (BBA) – Bioenergetics, v. 1857, n. 7, p. 938-945, jul, 2016.
ROSE, Shannon et al. Clinical and molecular characteristics of mitochondrial dysfunction in autism spectrum disorder. Molecular diagnosis & therapy, v. 22, n. 5, p. 571-593, jul, 2018.
ROSE, Shannon et al. Mitochondrial dysfunction in the gastrointestinal mucosa of children with autism: A blinded casecontrol study. PloS one, v. 12, n. 10, p. e0186377, oct, 2017.
ROSSIGNOL, Daniel A.; BRADSTREET, J. Jeffrey. Evidence of mitochondrial dysfunction in autism and implications for treatment. Am J Biochem Biotech, v. 4, n. 2, p. 208-217, feb, 2008.
SAUER, Ann Katrin et al. Altered intestinal morphology and microbiota composition in the autism spectrum disorders associated SHANK3 mouse model. International journal of molecular sciences, v. 20, n. 9, p. 2134, apr, 2019.
SRIKANTHA, Piranavie; MOHAJERI, M. Hasan. The Possible Role of the Microbiota-Gut-Brain-Axis in Autism Spectrum Disorder. International journal of molecular sciences, v. 20, n. 9, p. 2115, apr. 2019.
TAS, Ayten Aylin. Dietary strategies in autism spectrum disorder (ASD). Progress in Nutrition, v. 20, n. 4, p. 554 562, jul, 2018.
VAN SADELHOFF, Joris et al. The gut-immune-brain axis in autism spectrum disorders; a focus on amino acids. Frontiers in endocrinology, v. 1, p. 247, apr, 2019.
VAN SADELHOFF, Joris et al. The gut-immune-brain axis in autism spectrum disorders; a focus on amino acids. Frontiers in endocrinology, v. 10, p. 247, apr, 2019.
VEYRAT-DUREBEX, Charlotte et al. How can a ketogenic diet improve motor function?. Frontiers in molecular neuroscience, v. 11, p. 15, jan, 2018.
VINOGRADOV, Andrei D.; GRIVENNIKOVA, Vera G. Oxidation of NADH and ROS production by respiratory complex I. Biochimica et Biophysica Acta (BBA)-Bioenergetics, v. 1857, n. 7, p. 863-871, jul, 2016.
WHELESS, James W. History of the ketogenic diet. Epilepsia, v. 49, p. 3-5, nov, 2008.
YE, Fang et al. Efficacy of and patient compliance with a ketogenic diet in adults with intractable epilepsy: a metaanalysis. Journal of Clinical Neurology, v. 11, n. 1, p. 26-31, jan, 2015.
2025 © Instituto Priorit - Todos os direitos reservados.
Desenvolvido por UM Agência